Baxter International Inc
NYSE: BAX
$34.64
-$1.40 (-3.9%)
Closing Price on November 8, 2024
BAX Articles
US equity markets opened sharply higher this morning and have been able to sustain and even add to those gains throughout the day. Business and consumer confidence indexes in Europe were higher,...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) Added to Strong Buy List...
Published:
Last Updated:
Share repurchase programs, or stock buybacks, have been and may always be a more questionable method of returning capital to shareholders than dividends. Many even disagree with the effect of...
Published:
Last Updated:
These are this Tuesday morning’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Baxter International (NYSE: BAX) Cut to Hold at Citigroup. CIENA Corporation...
Published:
Last Updated:
Updated throughout the day. Update: RADVision (RVSN) is trading down over 33% on rumors that the Cisco (CSCO) buyout of Tandberg will cost it nearly 40% of its revenue. (Morgan Keegan) Update: ...
Published:
Last Updated:
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest...
Published:
These are the top big analyst calls from Wall Street we have seen very early this Friday morning with over two and a half hours until the market opens: Baidu (BIDU) Started as Underweight with $244...
Published:
Last Updated:
Baxter (NYSE: BAX) is probably retaining more lawyers. So far nineteen people have died from tainted Heparin, a blood-thinner. BAX is one of the largest marketers of the drug. According to The Wall...
Published:
Amicus Therapeutics (NASDAQ: FOLD) had a late afternoon surge, up 7% to $10.73. The 52 week range is $9.00 to $18.22. Baxter International (NYSE: BAX)—contaminant in recalled Heparin identified by...
Published:
According to Reuters, Toshiba will drop its HD DVD format. Reuters reports that Blll Gates said Microsoft (MSFT) will target web search with or without Yahoo! (YHOO) Reuters writes that RIM (RIMM)...
Published:
The uproar about Heparin, a widely-used drug marketed by Baxter International (NYSE: BAX), is just beginning. As The Wall Street Journal writes "Baxter said the active ingredient for its heparin was...
Published:
According to Reuters, Citigroup says UBS (UBS) may face another $18 billion in write-downs this year. Reuters writes that Alan Greenspan says the US is on the edge of recession. Reuters writes that...
Published:
Mattel (NYSE: MAT) may have feared it would wear the China "kick me" sign forever. Until Baxter (NYSE: BAX) came along. The new poster boy for not keeping an eye on China suppliers has pulled its...
Published:
According to Reuters, Yahoo! (YHOO) is in talks with News Corp (NWS) about an M&A deal but analysts say it is unlikely to work. Reuters writes that Paulson thinks the US economy will not go into...
Published:
Heparin, made Baxter International (NYSE: BAX) is one of the most widely used blood thinners in the world. Today’s disclosure that the U.S. Food and Drug Administration said it never inspected a...
Published: